The Supplier Code of Conduct
Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
Search
Performance Indicators
All available performance indicators concerning Environment Health and Safety (EHS) are summarised here. Click here to find out more information.
Circular economy
Plastic pollution is one of the most serious threats to the world’s oceans. Click here to find out how long it takes for garbage to dissolve in the oceans!
Trust Through Transparency
Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects. Click here to find out more information and learn more.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Boehringer Ingelheim China for a green future
Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.
Sant Cugat del Vallès
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Shanghai site.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Poultry Innovation Days 2018
As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
Our Expectations
We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. Click here to learn more.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Quick response in fighting Foot-and-Mouth-Disease
Colleagues from the Veterinary Public Health helped to contain an outbreak of Foot-and-Mouth Disease (FMD) on the island of Rodrigues in just six days.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Saving Stroke Patients around the world
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Click here to learn about the Angels Initiative.
Say no to the uninvited guests
Boehringer Ingelheim aims to raise awareness of the issues & risks that parasites can have on cats. Click here to find out more information.
COVID-19 Learning from the pandemic
Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
Development Biotechnology sustainable cell culture
Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint.